CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade PROCEPT BioRobotics Corp - PRCT CFD

62.21
4.75%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.23
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023512 %
Charges from full value of position ($-4.47)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023512%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00129 %
Charges from full value of position ($0.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00129%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 65.31
Open 66.18
1-Year Change 35.53%
Day's Range 62.18 - 66.18
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 21, 2025 62.21 -3.80 -5.76% 66.01 66.57 62.06
Feb 20, 2025 65.31 -1.85 -2.75% 67.16 68.20 65.18
Feb 19, 2025 67.15 0.70 1.05% 66.45 67.71 65.88
Feb 18, 2025 66.87 -0.70 -1.04% 67.57 68.14 66.16
Feb 14, 2025 67.51 -1.94 -2.79% 69.45 70.02 65.73
Feb 13, 2025 69.18 3.00 4.53% 66.18 69.26 64.95
Feb 12, 2025 66.06 1.28 1.98% 64.78 66.41 63.95
Feb 11, 2025 65.93 -2.63 -3.84% 68.56 68.56 65.79
Feb 10, 2025 69.70 -0.33 -0.47% 70.03 70.35 68.45
Feb 7, 2025 69.51 -1.23 -1.74% 70.74 73.13 69.20
Feb 6, 2025 70.72 -3.34 -4.51% 74.06 74.99 69.03
Feb 5, 2025 73.74 2.09 2.92% 71.65 73.85 70.95
Feb 4, 2025 71.51 0.21 0.29% 71.30 73.21 70.95
Feb 3, 2025 71.20 0.95 1.35% 70.25 72.40 70.12
Jan 31, 2025 72.40 0.86 1.20% 71.54 73.65 71.25
Jan 30, 2025 71.48 -1.73 -2.36% 73.21 73.99 70.60
Jan 29, 2025 72.89 0.03 0.04% 72.86 73.27 71.49
Jan 28, 2025 72.80 -1.36 -1.83% 74.16 74.45 71.78
Jan 27, 2025 74.64 2.53 3.51% 72.11 76.21 72.11
Jan 24, 2025 73.46 4.19 6.05% 69.27 73.83 69.27

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

PROCEPT BioRobotics Corporation Company profile

About Procept Biorobotics Corp

Procept Biorobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). Its AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. It designs Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Procept Biorobotics Corp revenues increased from $7.7M to $34.5M. Net loss increased 13% to $59.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Interest expense increase of 10% to $5.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.25 to -$1.38.

Industry: Medical Equipment, Supplies & Distribution (NEC)

900 Island Drive
Suite 210
REDWOOD CITY
CALIFORNIA 94065
US

People also watch

ETH/USD

2,779.27 Price
+5.290% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,936.56 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0149%
Short position overnight fee 0.0067%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

21,594.40 Price
-2.120% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

96,674.75 Price
+1.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading